A study has showed that TRPM8 over-expressed in advanced prostate cancer, and TRPM8 promoted cancer cell growth in vitro hypoxia, drug resistance, and in vivo tumorigenicity, with increased HIF-1α expression. This evidence concerns the gene TRPM8 and cancer.